These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 24635797

  • 1. Cytomegalovirus reactivation and preemptive therapy after liver transplant.
    Davoudi S, Kasraianfard A, Ahmadinejad Z, Najafi A, Salimi J, Makarem J, Sohrabpour AA, Jafarian A.
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():72-5. PubMed ID: 24635797
    [Abstract] [Full Text] [Related]

  • 2. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
    Aranda-Verástegui F, Alberú J, Soto-Ramírez LE, González-Aguirre H, Muñoz Trejo T, Mancilla E, Díliz H, Correa-Rotter R, Sierra-Madero J.
    Rev Invest Clin; 2002 Mar; 54(3):198-203. PubMed ID: 12183888
    [Abstract] [Full Text] [Related]

  • 3. Cytomegalovirus infection: its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: a single-center experience.
    Wadhawan M, Gupta S, Goyal N, Vasudevan KR, Makki K, Dawar R, Sardana R, Lal N, Kumar A.
    Liver Transpl; 2012 Dec; 18(12):1448-55. PubMed ID: 22903934
    [Abstract] [Full Text] [Related]

  • 4. Cytomegalovirus Treatment Strategy After a Liver Transplant: Preemptive Therapy or Prophylaxis for Cytomegalovirus Seropositive Donor and Recipient.
    Lindner K, Anthoni C, Beckebaum S, Senninger N, Hölzen JP, Wolters H.
    Exp Clin Transplant; 2016 Aug; 14(4):419-23. PubMed ID: 27506260
    [Abstract] [Full Text] [Related]

  • 5. Prophylactic acyclovir and preemptive ganciclovir to prevent cytomegalovirus disease in children after hematopoietic stem cell transplant.
    Tavil B, Azik FM, Bozkaya I, Gokcebay DG, Tezer H, Tunc B, Uckan D.
    Exp Clin Transplant; 2014 Oct; 12(5):462-8. PubMed ID: 25299374
    [Abstract] [Full Text] [Related]

  • 6. Comparison of antigenemia assay and semiquantitative polymerase chain reaction test for monitoring active cytomegalovirus infection in allogeneic hematopoietic cell transplant recipients.
    Pajand O, Ziyaeyan M, Mousavi S, Fatolahzadeh B, Hojabri Z, Bahador A, Abdossamadi Z.
    Exp Clin Transplant; 2008 Jun; 6(2):149-54. PubMed ID: 18816243
    [Abstract] [Full Text] [Related]

  • 7. Comparison of intravenous ganciclovir and cytomegalovirus hyperimmune globulin pre-emptive treatment in cytomegalovirus-positive heart transplant recipients.
    Vrtovec B, Thomas CD, Radovancevic R, Frazier OH, Radovancevic B.
    J Heart Lung Transplant; 2004 Apr; 23(4):461-5. PubMed ID: 15063406
    [Abstract] [Full Text] [Related]

  • 8. Long-term renal graft function and survival in patients with high-risk for cytomegalovirus infection receiving preemptive therapy.
    Alberú J, Morales-Buenrostro LE, Correa-Rotter R, Muñoz-Trejo T, Zúñiga-Varga J, Cuéllar-González JV, Mayorga-Madrigal H, Vanegas-Carrero R, Aranda F, Rodríguez-Romo R, Herrera-Garcia C, González-Michaca L, Sierra-Madero JG.
    Rev Invest Clin; 2008 Apr; 60(5):365-74. PubMed ID: 19227433
    [Abstract] [Full Text] [Related]

  • 9. Prospective randomized trial to assess the value of preemptive oral therapy for CMV infection following liver transplantation.
    Rayes N, Seehofer D, Schmidt CA, Oettle H, Müller AR, Steinmüller T, Settmacher U, Bechstein WO, Neuhaus P.
    Transplantation; 2001 Sep 15; 72(5):881-5. PubMed ID: 11571454
    [Abstract] [Full Text] [Related]

  • 10. Prophylaxis followed by preemptive therapy versus preemptive therapy for prevention of human cytomegalovirus disease in pediatric patients undergoing liver transplantation.
    Gerna G, Lilleri D, Callegaro A, Goglio A, Cortese S, Stroppa P, Torre G.
    Transplantation; 2008 Jul 15; 86(1):163-6. PubMed ID: 18622294
    [Abstract] [Full Text] [Related]

  • 11. Prophylaxis versus preemptive therapy for cytomegalovirus disease in high-risk liver transplant recipients.
    Bodro M, Sabé N, Lladó L, Baliellas C, Niubó J, Castellote J, Fabregat J, Rafecas A, Carratalà J.
    Liver Transpl; 2012 Sep 15; 18(9):1093-9. PubMed ID: 22532316
    [Abstract] [Full Text] [Related]

  • 12. Valganciclovir as preemptive therapy for cytomegalovirus in cytomegalovirus-seronegative liver transplant recipients of cytomegalovirus-seropositive donor allografts.
    Singh N, Wannstedt C, Keyes L, Mayher D, Tickerhoof L, Akoad M, Wagener MM, Cacciarelli TV.
    Liver Transpl; 2008 Feb 15; 14(2):240-4. PubMed ID: 18236404
    [Abstract] [Full Text] [Related]

  • 13. [Impact of initial cytomegalovirus viral load on efficacy of preemptive therapy with ganciclovir in allogeneic stem cell transplant recipients].
    Torre-Cisneros J, Caston-Osorio JJ, Martín C, Rivero A, Doblas A, Rojas R, Gómez P, Martínez F, Torres A.
    Enferm Infecc Microbiol Clin; 2010 Jan 15; 28(1):6-12. PubMed ID: 19409666
    [Abstract] [Full Text] [Related]

  • 14. Combined antiviral and immunoglobulin therapy as prophylaxis against cytomegalovirus infection after heart transplantation.
    Valenza M, Czer LS, Pan SH, Aleksic I, Freimark D, Harasty DA, Admon D, Barath P, Blanche C, Trento A.
    J Heart Lung Transplant; 1995 Jan 15; 14(4):659-65. PubMed ID: 7578172
    [Abstract] [Full Text] [Related]

  • 15. Detection of CMV-DNA in peripheral blood leukocytes of liver transplant patients after ganciclovir treatment.
    Loginov R, Höckerstedt K, Lautenschlager I.
    Arch Virol; 2003 Jul 15; 148(7):1269-74. PubMed ID: 12827460
    [Abstract] [Full Text] [Related]

  • 16. Sequential cytomegalovirus antigenemia monitoring in kidney transplant patients treated with antilymphocyte antibodies.
    Ozaki KS, Pestana JO, Granato CF, Pacheco-Silva A, Camargo LF.
    Transpl Infect Dis; 2004 Jun 15; 6(2):63-8. PubMed ID: 15522106
    [Abstract] [Full Text] [Related]

  • 17. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
    Lo CY, Ho KN, Yuen KY, Lui SL, Li FK, Chan TM, Lo WK, Cheng IK.
    Clin Transplant; 1997 Aug 15; 11(4):286-93. PubMed ID: 9267717
    [Abstract] [Full Text] [Related]

  • 18. [pp65 antigenemia in evaluation of cytomegalovirus infection after kidney transplantation].
    Orlić P, Dvornik S, Husnjak SC, Aralica M, Orlić L, Zivcić-Cosić S, Sladoje-Martinović B, Fućak M.
    Acta Med Croatica; 2003 Aug 15; 57(1):49-52. PubMed ID: 12876863
    [Abstract] [Full Text] [Related]

  • 19. Use of the cytomegalovirus pp65 antigenemia assay for preemptive therapy in allogeneic hematopoietic stem cell transplantation: a real-world review.
    Tan BH, Chlebicka NL, Low JG, Chong TY, Chan KP, Goh YT.
    Transpl Infect Dis; 2008 Oct 15; 10(5):325-32. PubMed ID: 18627578
    [Abstract] [Full Text] [Related]

  • 20. A short-term preemptive treatment for cytomegalovirus infection in seropositive patients after liver transplantation.
    Dahiya D, Lee CF, Chan KM, Wu TJ, Chou HS, Cheng SS, Lee WC.
    J Hepatobiliary Pancreat Sci; 2011 Jan 15; 18(1):32-8. PubMed ID: 20499109
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.